TrialTrials2022

Rationale and methods of the Antioxidant and NMDA receptor blocker Weans Anoxic brain damage of KorEa OHCA patients (AWAKE) trial.

Jin-Ho Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.